TB-500 is a research-market peptide designation commonly associated with thymosin beta-4-related materials. It is supplied as a lyophilised research material for controlled laboratory studies of actin dynamics, cell migration, angiogenic signalling and tissue-remodelling pathways.
Research material only
This material is not supplied as a medicine, treatment, supplement or consumer product. It is not for human or veterinary use, consumption or administration, and is not intended to diagnose, treat, cure or prevent any disease.
Compound overview
Research context
Thymosin beta-4 is a naturally occurring 43-amino-acid peptide investigated for its interaction with actin and for its roles in cell migration, endothelial-cell behaviour, angiogenic signalling and tissue-remodelling models. TB-500 is a research-market designation commonly associated with thymosin beta-4-related materials; the name alone does not establish that a particular material is chemically identical to the full-length peptide used in published studies.
The linked research should therefore be treated as scientific context rather than evidence of identity, performance or suitability for the material supplied on this page. Material identity and batch-specific characteristics should be assessed using the applicable analytical documentation.
Batch documentation
Independent analytical documentation is published where available for specific batches and variations. A result indicator appears only when a published record is available. Match the vial size and batch identifier to the corresponding report before relying on any result.
VIEW AVAILABLE TB-500 LAB RESULTS →
Supply and laboratory handling
- Supplied in the vial size selected above.
- Provided as a lyophilised material for laboratory research.
- Use calibrated equipment and an independently validated protocol appropriate to the intended study.
- Record the product designation, vial size, batch identifier and preparation conditions in the laboratory record.
Frequently asked questions
What is TB-500?
TB-500 is a research-market peptide designation commonly associated with thymosin beta-4-related materials. It is supplied here solely as a laboratory research material.
Is TB-500 necessarily identical to thymosin beta-4?
No. The TB-500 name alone does not establish chemical identity with the full-length 43-amino-acid thymosin beta-4 used in published studies. Consult the applicable product and batch documentation.
What research is linked on this page?
The Research tab links to publications concerning full-length thymosin beta-4, including actin binding, cell migration, endothelial-cell behaviour and wound-model research. These sources provide related scientific context and are not product-performance claims.
Which vial sizes are available?
Current vial sizes and availability are shown in the size selector above. This information updates with the product variations rather than being fixed in the description.
Are published laboratory results available?
Where a published batch record exists, a result indicator appears beside the applicable variation and the corresponding documentation is available on the lab-results page. No indicator means that no product-specific published result is currently displayed for that variation.
How should TB-500 be stored?
Protect sealed lyophilised vials from light, moisture and repeated temperature changes. After reconstitution, store the reconstituted solution refrigerated at 2–8°C and follow a validated laboratory protocol for handling and use.
Information reviewed 29 August 2026.
